Mutations in nonstructural proteins essential for pathogenicity in SARS-CoV-2-infected mice

被引:0
|
作者
Pan, Ruangang [1 ]
Li, Pengfei [1 ]
Meyerholz, David K. [2 ]
Perlman, Stanley [1 ,3 ]
机构
[1] Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA 52242 USA
[2] Univ Iowa, Dept Pathol, Iowa City, IA USA
[3] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA
基金
美国国家卫生研究院;
关键词
SARS-CoV-2; mouse adapted coronavirus; nsp4; nsp8; innate immune response;
D O I
10.1128/jvi.00584-24
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) has resulted in substantial morbidity and mortality. The basis of severe disease in humans is difficult to determine without the use of experimental animal models. Mice are resistant to infection with ancestral strains of SARS-CoV-2, although many variants that arose later in the pandemic were able to directly infect mice. In almost all cases, viruses that naturally infected mice or were engineered to enable mouse infection required mouse passage to become virulent. In most cases, changes in structural and nonstructural changes occurred during mouse adaptation. However, the mechanism of increased virulence in mice is not understood. Here, using a recently described strain of mouse-adapted SARS-CoV-2 (rSARS2-MA30N501Y), we engineered a series of recombinant viruses that expressed a subset of the mutations present in rSARS2-MA30N501Y. Mutations were detected in the spike protein and in three nonstructural proteins (nsp4, nsp8, and nsp9). We found that infection of mice with recombinant SARS-CoV-2 expressing only the S protein mutations caused very mild infection. Addition of the mutations in nsp4 and nsp8 was required for complete virulence. Of note, all these recombinant viruses replicated equivalently in cultured cells. The innate immune response was delayed after infection with virulent compared to attenuated viruses. Further, using a lineage tracking system, we found that attenuated virus was highly inhibited in the ability to infect the parenchyma, but not the airway after infection. Together, these results indicate that mutations in both the S protein and nonstructural proteins are required for maximal virulence during mouse adaptation. IMPORTANCE Understanding the pathogenesis of coronavirus disease 2019 (COVID-19) requires the study of experimental animals after infection with severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). For this purpose, several mouse-adapted SARS-CoV-2 strains have been developed. Here, using a strain of mouse-adapted virus that causes a range of diseases ranging from mild to severe, we show that mutations in both a structural protein [spike (S) protein] and nonstructural proteins are required for maximal virulence. Thus, changes in the S protein, the most widely studied viral protein, while required for mouse adaptation, are not sufficient to result in a virulent virus. Understanding the pathogenesis of coronavirus disease 2019 (COVID-19) requires the study of experimental animals after infection with severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). For this purpose, several mouse-adapted SARS-CoV-2 strains have been developed. Here, using a strain of mouse-adapted virus that causes a range of diseases ranging from mild to severe, we show that mutations in both a structural protein [spike (S) protein] and nonstructural proteins are required for maximal virulence. Thus, changes in the S protein, the most widely studied viral protein, while required for mouse adaptation, are not sufficient to result in a virulent virus.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Outcome of SARS-CoV-2-Infected Polish Patients with Chronic Lymphocytic Leukemia
    Pula, Bartosz
    Pruszczyk, Katarzyna
    Pietrusza, Ewa
    Morawska, Marta
    Piszczek, Weronika
    Kalicinska, Elzbieta
    Szeremet, Agnieszka
    Tryc-Szponder, Jagoda
    Wasik-Szczepanek, Ewa
    Drozd-Sokolowska, Joanna
    Krzemien, Helena
    Rejus, Aleksandra
    Gajewska, Malgorzata
    Wisniewski, Kamil
    Wysocki, Maciej
    Majeranowski, Alan
    Paszkiewicz-Kozik, Ewa
    Steckiewicz, Pawel
    Szukalski, Lukasz
    Bolkun, Lukasz
    Dlugosz-Danecka, Monika
    Giannopoulos, Krzysztof
    Jamroziak, Krzysztof
    Lech-Maranda, Ewa
    Hus, Iwona
    CANCERS, 2022, 14 (03)
  • [42] Abnormal antibodies to self-carbohydrates in SARS-CoV-2-infected patients
    Butler, Dorothy L.
    Imberti, Luisa
    Quaresima, Virginia
    Fiorini, Chiara
    Gildersleeve, Jeffrey C.
    PNAS NEXUS, 2022, 1 (03):
  • [43] Neurological features in SARS-CoV-2-infected patients with smell and taste disorder
    Antoniangela Cocco
    Paolo Amami
    Antonio Desai
    Antonio Voza
    Fabio Ferreli
    Alberto Albanese
    Journal of Neurology, 2021, 268 : 1570 - 1572
  • [44] Transient Lymphopenia and Interstitial Pneumonia With Endotheliitis in SARS-CoV-2-Infected Macaques
    Koo, Bon-Sang
    Oh, Hanseul
    Kim, Green
    Hwang, Eun-Ha
    Jung, Hoyin
    Lee, Youngjeon
    Kang, Philyong
    Park, Jae-Hak
    Ryu, Choong-Min
    Hong, Jung Joo
    JOURNAL OF INFECTIOUS DISEASES, 2020, 222 (10): : 1596 - 1600
  • [45] On evolution model for SARS-Cov-2-infected population: the case of New Zealand
    Khmaladze, Estate
    Kvizhinadze, Giorgi
    JOURNAL OF APPLIED STATISTICS, 2023, 50 (11-12) : 2435 - 2449
  • [46] Critically ill SARS-CoV-2-infected patients are not stratified as sepsis by the qSOFA
    Ferreira, Marion
    Blin, Timothee
    Collercandy, Nived
    Szychowiak, Piotr
    Dequin, Pierre-Francois
    Jouan, Youenn
    Guillon, Antoine
    ANNALS OF INTENSIVE CARE, 2020, 10 (01)
  • [47] Viral and Host Transcriptomes in SARS-CoV-2-Infected Human Lung Cells
    Wang, Xuefeng
    Zhao, Yudong
    Yan, Feihu
    Wang, Tiecheng
    Sun, Weiyang
    Feng, Na
    Wang, Wenqi
    Wang, Hongmei
    He, Hongbin
    Yang, Songtao
    Xia, Xianzhu
    Gao, Yuwei
    JOURNAL OF VIROLOGY, 2021, 95 (18)
  • [48] Immune-mediated neurological syndromes in SARS-CoV-2-infected patients
    Guilmot, Antoine
    Slootjes, Sofia Maldonado
    Sellimi, Amina
    Bronchain, Maroussia
    Hanseeuw, Bernard
    Belkhir, Leila
    Yombi, Jean Cyr
    De Greef, Julien
    Pothen, Lucie
    Yildiz, Halil
    Duprez, Thierry
    Fillee, Catherine
    Anantharajah, Ahalieyah
    Capes, Antoine
    Hantson, Philippe
    Jacquerye, Philippe
    Raymackers, Jean-Marc
    London, Frederic
    El Sankari, Souraya
    Ivanoiu, Adrian
    Maggi, Pietro
    van Pesch, Vincent
    JOURNAL OF NEUROLOGY, 2021, 268 (03) : 751 - 757
  • [49] Dynamics of the Immune Response in Hospitalized SARS-CoV-2-infected Cancer Patients
    Aoki, Mateus Nobrega
    Nardin, Jeanine Marie
    Huergo, Luciano Fernandes
    Blanes, Lucas
    Paz Morales, Hugo Manuel
    Fornazari, Bruna
    Conzentino, Marcelo Santos
    Alencar Migliorini, Maria Eduarda
    Zanette, Dalila Luciola
    CANCER INVESTIGATION, 2022, 40 (09) : 750 - 759
  • [50] MiRNA Profiling in Plasma and Placenta of SARS-CoV-2-Infected Pregnant Women
    Saulle, Irma
    Garziano, Micaela
    Fenizia, Claudio
    Cappelletti, Gioia
    Parisi, Francesca
    Clerici, Mario
    Cetin, Irene
    Savasi, Valeria
    Biasin, Mara
    CELLS, 2021, 10 (07)